Zyden Gentec was incorporated on April 26, 1994 under the companies Act 1956 as Overseas Capital Private Limited. The name of the company was changed to Overseas Capital Limited on conversion into public limited company on November 11, 1994 and to Zyden Gentec Limited on July 16, 2004. The company was promoted by RK Dhar.

Initially the company was engaged in providing financial services and is presently engaged in the manufacturing of pharmaceuticals and fine chemicals.

Product range of the company includes:

The company's principal activity is to manufacture pharmaceutical products and to provide concultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates

• Drotaverine HCL
• Levocetrizine
• Ketoconazole
• Sildenafil Citrate
• Glucosamine
• Ciprofloxacin HCL
• Enro Floxacin
• Bypyridine
• Guaifenesin